Mikhail Pechenkin Email and Phone Number

Managed a project of technology transfer to a new CMO (for company peptide drugs). Provided technical support for launch of newly registered drug routine manufacturing. Run product development experiments for new potential drugs in a company pipeline.

Provided technical support for biotech customers with Sartoruis downstream/filtration products (Filtration/virus filtration/TFF/chromatography systems, columns, resins, monolithic columns etc.). Installed and helped with installation of new equipment. Provided product support for sales team. Presented company portfolio during an international exhibition.

Supervised and supported tech transfer for a plasmatic FVIII drug product. Maintained constant interaction with a European technology provider. Managed trial batch manufacturing & process scale-up. Coordinated reagents, expendables & equipment procurement for a process development purposes, as well as for a full-scale process design of a new production facility. Performed additional studies for isolation of an additional product (fibrinogen) from side fractions of the initial process.

Carried out project management activities for drug product development/formulation changes/tech. transfer projects. Managed project teams, timelines and budget control throughout the project life cycles. Interacted with contractors and managed contract negotiation.

Managed Formulation Development laboratory and technology transfer from the parent company. Developed highly targeted, antigen-specific and tolerogenic immunotherapies for life-threatening diseases using company platform.Project of from scratch development of an antigen-adjuvant complex system for therapeutic vaccine against HPV-16 associated cervical cancer has been included in the parent company IPO prospectus. Proof-of-concept in vivo studies, toxicology studies on animal models and… Show more Managed Formulation Development laboratory and technology transfer from the parent company. Developed highly targeted, antigen-specific and tolerogenic immunotherapies for life-threatening diseases using company platform.Project of from scratch development of an antigen-adjuvant complex system for therapeutic vaccine against HPV-16 associated cervical cancer has been included in the parent company IPO prospectus. Proof-of-concept in vivo studies, toxicology studies on animal models and process scale up for preclinical batch manufacturing has been performed. Show less

Development of peroral insulin formulation. Protein encapsulation, prevention of protein cleavage by intestinal proteases, in vitro study on enzyme insulin degradation, improvement of oral bioavailability, in vivo (rats/rabbits) studies of insulin-loaded microparticles, development of assay of chitosan.Development of antioxidant nanoparticles for spinal cord injury treatment. Transfer of nanozyme preparation and characterization technology; further application & development of technology at… Show more Development of peroral insulin formulation. Protein encapsulation, prevention of protein cleavage by intestinal proteases, in vitro study on enzyme insulin degradation, improvement of oral bioavailability, in vivo (rats/rabbits) studies of insulin-loaded microparticles, development of assay of chitosan.Development of antioxidant nanoparticles for spinal cord injury treatment. Transfer of nanozyme preparation and characterization technology; further application & development of technology at MSU (study funded by Grant of the Government of the Russian Federation). Show less

Training in the Technology of Nanozyme Preparation, Purification, and Analysis; technology transfer to MSU.

Sponge-like microparticles from CaCO3 – high surface reservoirs for effective substances embedding. The project has been supported by DAAD (German Academic Exchange Service), personal grant.